Cargando…

Fn14-targeted BiTE and CAR-T cells demonstrate potent preclinical activity against glioblastoma

T cell-engaging therapies involving bispecific T cell engager (BiTE) and chimeric antigen receptor T (CAR-T) cells have achieved great success in the treatment of hematological tumors. However, the paucity of ideal cell surface molecules that can be targeted on glioblastoma (GBM) partially reduces t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Gaowei, Zhang, Zongliang, Cai, Linjun, Tang, Xin, Huang, Jianhan, Yu, Lingyu, Wang, Guoqing, Zhong, Kunhong, Cao, Yi, Liu, Chang, Wang, Yuelong, Tong, Aiping, Zhou, Liangxue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477963/ https://www.ncbi.nlm.nih.gov/pubmed/34595061 http://dx.doi.org/10.1080/2162402X.2021.1983306

Ejemplares similares

Efficacy of B7-H3-Redirected BiTE and CAR-T Immunotherapies Against Extranodal Nasal Natural Killer/T Cell Lymphoma
por: Zheng, Meijun, et al.
Publicado: (2020)

B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors
por: Zhang, Zongliang, et al.
Publicado: (2020)

Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors
por: Yang, Meijia, et al.
Publicado: (2020)

Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities
por: Wang, Guoqing, et al.
Publicado: (2022)

B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
por: Tang, Xin, et al.
Publicado: (2019)

AP-64, Encoded by C5orf46, Exhibits Antimicrobial Activity against Gram-Negative Bacteria
por: Zhong, Kunhong, et al.
Publicado: (2021)

Administration of B7-H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma
por: Tang, Xin, et al.
Publicado: (2021)

Lipid Nanoparticle Delivery System for mRNA Encoding B7H3‐redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors
por: Huang, Cheng, et al.
Publicado: (2022)

Loss of furin site enhances SARS-CoV-2 spike protein pseudovirus infection
por: Wang, Zeng, et al.
Publicado: (2023)

CAR-T cells and BiTEs in solid tumors: challenges and perspectives
por: Edeline, Julien, et al.
Publicado: (2021)

Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and Beyond
por: Epperly, Rebecca, et al.
Publicado: (2020)

Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
por: Kegyes, David, et al.
Publicado: (2022)

BiTE‐Secreting CAR‐γδT as a Dual Targeting Strategy for the Treatment of Solid Tumors
por: Huang, Shi‐Wei, et al.
Publicado: (2023)

Genome-scale CRISPR–Cas9 screen reveals novel regulators of B7-H3 in tumor cells
por: Zhao, Shasha, et al.
Publicado: (2022)

Bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor T cells against anaplastic meningioma
por: Tang, Xin, et al.
Publicado: (2020)

A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)
por: Stone, Jennifer D., et al.
Publicado: (2012)

Structure of unliganded membrane-proximal domains FN4-FN5-FN6 of DCC
por: Finci, Lorenzo I., et al.
Publicado: (2017)

Immunotherapy using bispecific T cell engager (BiTE(®)) antibodies: preclinical and clinical experience in acute leukemia
por: Subklewe, Marion, et al.
Publicado: (2014)

GPC3-targeted CAR-T cells secreting B7H3-targeted BiTE exhibit potent cytotoxicity activity against hepatocellular carcinoma cell in the in vitro assay
por: Cao, Guozheng, et al.
Publicado: (2022)

Immunotherapy of glioblastoma: Recent advances and future prospects
por: Yuan, Boyang, et al.
Publicado: (2022)

Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience
por: Huang, Jianhan, et al.
Publicado: (2020)

T cell stimulation and expansion by SunTag-based clustering of anti-CD3/CD28 scFv
por: Zhong, Kunhong, et al.
Publicado: (2020)

VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells
por: Kulemzin, Sergey V., et al.
Publicado: (2018)

A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain
por: Wojcik, John, et al.
Publicado: (2010)

Evaluation of B7-H3 Targeted Immunotherapy in a 3D Organoid Model of Craniopharyngioma
por: Tang, Mei, et al.
Publicado: (2022)

Implications for Collagen Binding from the Crystallographic Structure of Fibronectin (6)FnI(1–2)FnII(7)FnI
por: Erat, Michèle C., et al.
Publicado: (2010)

Novel Immune Engagers and Cellular Therapies for Metastatic Castration-Resistant Prostate Cancer: Do we take a BiTe or ride BiKEs, TriKEs, and CARs?
por: Zorko, Nicholas A., et al.
Publicado: (2021)

CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing
por: Andersch, Lena, et al.
Publicado: (2019)

Direct comparison of target-reactivity and cross-reactivity induced by CAR- and BiTE-redirected T cells for the development of antibody-based T-cell therapy
por: Maruta, Masaki, et al.
Publicado: (2019)

MEK Inhibitor Augments Antitumor Activity of B7-H3-Redirected Bispecific Antibody
por: Li, Hongjian, et al.
Publicado: (2020)

The bi-objective multimodal car-sharing problem
por: Enzi, Miriam, et al.
Publicado: (2021)

Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models
por: Teuscher, Kevin B., et al.
Publicado: (2022)

Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma
por: Tatari, Nazanin, et al.
Publicado: (2020)

Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients
por: Abid, Muhammad Bilal, et al.
Publicado: (2022)

Contextual Impairments in Schizophrenia and the FN400
por: Amoruso, Lucia, et al.
Publicado: (2012)

TWEAK and Fn14 in the Neurovascular Unit
por: Yepes, Manuel
Publicado: (2013)

Humanized Mice Are Precious Tools for Preclinical Evaluation of CAR T and CAR NK Cell Therapies
por: Mhaidly, Rana, et al.
Publicado: (2020)

EGF and curcumin co-encapsulated nanoparticle/hydrogel system as potent skin regeneration agent
por: Li, Xiaoling, et al.
Publicado: (2016)

The Multivalent Role of Fibronectin-Binding Proteins A and B (FnBPA and FnBPB) of Staphylococcus aureus in Host Infections
por: Speziale, Pietro, et al.
Publicado: (2020)

Rapid manufacturing of non-activated potent CAR T cells
por: Ghassemi, Saba, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mn8vd5u4qda8cb75uukcvfttka